treatment-resistant depression

Neurolief previously received Breakthrough Device designation from the FDA for its technology targeting Major Depression

This ascent is propelled by favorable regulatory developments, including pioneering clinical trial guidelines from the FDA

The drug indicated to treat adults with major depressive disorder and acute suicidal ideation or behaviour reportedly begins…